FDA and industry weigh broader use of prior knowledge in biotechnology testing and production. Efforts to streamline the development of new medicines, particularly breakthrough therapies, are focusing ...

After the FDA’s first-ever public listening meeting on data-sharing in the cell and gene therapy space, new draft guidance aims to standardize the practice. But recent decisions call into question ...

Prior Knowledge debuted Veritable, a predictive database for application developers at Disrupt San Francisco 2012 today. Based upon work first done at MIT, the service is offered through the company’s ...